標題: Titlebook: Cancer Chemotherapy: an Introduction; T. J. Priestman Book 1989Latest edition Springer-Verlag Berlin Heidelberg 1989 Drogen.antibiotics.br [打印本頁] 作者: 瘦削 時間: 2025-3-21 18:53
書目名稱Cancer Chemotherapy: an Introduction影響因子(影響力)
書目名稱Cancer Chemotherapy: an Introduction影響因子(影響力)學科排名
書目名稱Cancer Chemotherapy: an Introduction網(wǎng)絡公開度
書目名稱Cancer Chemotherapy: an Introduction網(wǎng)絡公開度學科排名
書目名稱Cancer Chemotherapy: an Introduction被引頻次
書目名稱Cancer Chemotherapy: an Introduction被引頻次學科排名
書目名稱Cancer Chemotherapy: an Introduction年度引用
書目名稱Cancer Chemotherapy: an Introduction年度引用學科排名
書目名稱Cancer Chemotherapy: an Introduction讀者反饋
書目名稱Cancer Chemotherapy: an Introduction讀者反饋學科排名
作者: 地牢 時間: 2025-3-21 22:47 作者: 良心 時間: 2025-3-22 01:10 作者: BUMP 時間: 2025-3-22 05:18
Patrizio Blandina,Maria Beatrice Passanicrease the chance of later developing a cancer. It is important to stress that this is only a theoretical possibility and that there is, as yet, no definite link between previous professional contact with cytotoxics and subsequent development of cancer. Even so, the possibility of a long-term hazard作者: galley 時間: 2025-3-22 12:31 作者: duplicate 時間: 2025-3-22 13:08 作者: duplicate 時間: 2025-3-22 19:49
Book 1989Latest editiongly. The four chapters in the last edition which dealt with the team approach to cancer therapy have been replaced by a single chapter on the place of chemotherapy in the overall treatment of cancer. Unfortunately, despite all the innovations of the last decade, it has become increasingly clear that作者: incredulity 時間: 2025-3-22 21:46 作者: 地殼 時間: 2025-3-23 03:03
Kenneth M. Verburg,David P. Henrytient. In practice, with a few exceptions, this is not possible. Two factors prevent the universal success of chemotherapy in cancer treatment: drug resistance (see Chapter 7) and the dose-limiting toxicity of cytotoxic drugs.作者: 緩解 時間: 2025-3-23 06:18 作者: 掃興 時間: 2025-3-23 10:21 作者: Diluge 時間: 2025-3-23 15:12
The Place of Chemotherapy in Cancer Treatmenteat majority of cancer cures today. This is especially true in the solid tumours, the carcinomas and sarcomas, which account for over 90 per cent of cancers, where, with the possible exception of early breast cancer and a few uncommon conditions, chemotherapy has yet to make any significant impact on cure rates or survival times.作者: Mendicant 時間: 2025-3-23 19:03 作者: ADAGE 時間: 2025-3-24 01:00 作者: 難取悅 時間: 2025-3-24 03:31 作者: ADAGE 時間: 2025-3-24 07:05 作者: Urologist 時間: 2025-3-24 14:11
Mieczys?aw Pokorski,Sandra Klimańskalated by events such as the thalidomide tragedy, increasing statutory controls on new drug development were introduced during the 1950s and 1960s. During the same period the principles of clinical assessment became more clearly defined and a relatively uniform pattern of evaluation has emerged.作者: ALIBI 時間: 2025-3-24 17:31
Gregory J. Wastek,Henry I. Yamamuraver, genetically similar and thus what Ehrlich had recorded was the general phenomenon of transplant rejection rather than a specific antitumour effect. Despite this setback the possibility of stimulating the host’s own defences to recognise malignant tissue as foreign and bring about its destruction has been vigorously pursued over the years.作者: Neolithic 時間: 2025-3-24 22:09
Nian-Hang Chen,Maarten E. A. Reithand many previously uniformly fatal tumours are now curable in a high proportion of children. Table 14.1 summarises the relative incidence and changing survival rates of the various childhood cancers. The leukaemias, lymphomas and osteosarcoma will be discussed in subsequent chapters.作者: 曲解 時間: 2025-3-24 23:59
Principles of Tumour Growth which is essential for the processes of repair and replacement. A basic knowledge of the growth patterns of both these normal tissues and malignant cell populations is fundamental to an understanding of the drug treatment of cancer.作者: SOW 時間: 2025-3-25 06:09 作者: 消散 時間: 2025-3-25 10:15
Resistance to Cytotoxic Drugs will reappear and the patient relapse despite continuing chemotherapy. This progression of disease during treatment indicates that the tumour has developed secondary resistance to the particular drugs being given. A change of agents at this time may well bring about a further remission.作者: Serenity 時間: 2025-3-25 12:13 作者: 暴露他抗議 時間: 2025-3-25 16:02 作者: GREEN 時間: 2025-3-25 21:03 作者: 針葉 時間: 2025-3-26 02:55 作者: Admire 時間: 2025-3-26 05:45
Book 1989Latest editiong time, there have been numerous developments in cancer chemotherapy and in order to cover these the majority of the text has been completely revised and rewritten. In addition, two new chapters have been introduced, one on the safe handling of cytotoxic drugs and the other on biological response mo作者: Amplify 時間: 2025-3-26 10:26 作者: NATTY 時間: 2025-3-26 15:17
Enkephalin and Endorphin Receptors,At least three agents with anti-oestrogenic properties have been used in cancer treatment: tamoxifen, clomiphene citrate and nafoxidene. It is tamoxifen, however, that has come to dominate this particular therapeutic area and the remainder of this discussion will be confined to this agent.作者: ADAGE 時間: 2025-3-26 19:56
The Clinical Pharmacology of Endocrine DrugsAt least three agents with anti-oestrogenic properties have been used in cancer treatment: tamoxifen, clomiphene citrate and nafoxidene. It is tamoxifen, however, that has come to dominate this particular therapeutic area and the remainder of this discussion will be confined to this agent.作者: 小淡水魚 時間: 2025-3-26 21:36 作者: FEMUR 時間: 2025-3-27 02:47 作者: Factorable 時間: 2025-3-27 08:24
https://doi.org/10.1007/978-1-4471-1686-8Drogen; antibiotics; brain; breast cancer; cancer; cancer therapy; carcinoma; chemotherapy; drug; drug resist作者: 樸素 時間: 2025-3-27 12:04 作者: Oafishness 時間: 2025-3-27 14:58 作者: 法律的瑕疵 時間: 2025-3-27 18:30
Alan A. Boulton,Glen B. Baker,Peter H. Yusly treated, it leads to the death of the host. In healthy adults, however, many normal tissues contain actively multiplying cells, the replication of which is essential for the processes of repair and replacement. A basic knowledge of the growth patterns of both these normal tissues and malignant c作者: 清唱劇 時間: 2025-3-27 22:37 作者: Esalate 時間: 2025-3-28 03:47 作者: 共和國 時間: 2025-3-28 10:20
D. A. Redburn,C. K. Mitchell,C. K. Hampton guidance as to how the drugs should be used. As time went by results from clinical and laboratory studies provided some facts, and many theories, a number of which significantly influenced the development of chemotherapeutic practice. In this chapter the evolution of the use of cytotoxic drugs will作者: Nomogram 時間: 2025-3-28 12:43
Edward D. Levin,Roger W. Russell on normal tissues. A number of techniques have been developed in an attempt to overcome the problems created by drug toxicity, in the hope of allowing higher doses of cytotoxics to be given, thereby increasing the chance of cure. Before considering the prevention and management of specific side eff作者: Outshine 時間: 2025-3-28 15:52 作者: 發(fā)炎 時間: 2025-3-28 21:54 作者: 比賽用背帶 時間: 2025-3-29 02:46 作者: 顯而易見 時間: 2025-3-29 04:57
Mieczys?aw Pokorski,Sandra Klimańskainimum of preclinical testing. The subsequent clinical evaluation of toxicity and efficacy was often crude and superficial by today’s standards. Stimulated by events such as the thalidomide tragedy, increasing statutory controls on new drug development were introduced during the 1950s and 1960s. Dur作者: fastness 時間: 2025-3-29 07:33 作者: 承認 時間: 2025-3-29 13:10 作者: 誘導 時間: 2025-3-29 18:46 作者: 證明無罪 時間: 2025-3-29 23:48 作者: Living-Will 時間: 2025-3-30 03:07
Raul R. Gainetdinov,Marc G. Caronght about a dramatic improvement in the prognosis for many of these tumours, offering the possibility of cure in a significant number of patients. The haematological cancers are a very diverse group of diseases, the principal members of which are the leukaemias and lymphomas. The leukaemias are char作者: 特征 時間: 2025-3-30 04:16 作者: 恃強凌弱 時間: 2025-3-30 08:44
https://doi.org/10.1007/978-3-319-10006-7f other methods of administration have been devised to try and ensure optimal drug delivery in a variety of different clinical situations. This chapter summarises these techniques, their rationale and indications.作者: 重疊 時間: 2025-3-30 16:16
